What patients tell us
“I had mono in college, or I think I did. Now I get a cold and I'm down for two weeks. My lymph nodes are always tender. I'm exhausted in a way that's different from being tired. My doctor says my EBV levels are 'normal for someone who had mono' and there's nothing more to investigate.”
Why chronic viral reactivation matters clinically
Epstein-Barr virus and cytomegalovirus are both members of the herpesvirus family — viruses that establish lifelong latency after initial infection. Roughly 90 to 95 percent of adults are seropositive for EBV; 50 to 80 percent are seropositive for CMV. The viruses remain in the body indefinitely after initial exposure, controlled by the immune system but capable of reactivating under conditions of immune dysregulation, stress, or other triggers.
In immunocompetent patients, EBV and CMV reactivation has historically been considered clinically insignificant outside specific contexts. The framework emerging from more recent research is that subclinical viral reactivation in otherwise immunocompetent patients may contribute meaningfully to chronic illness — particularly in patients with fatigue, immune dysregulation, autoimmune patterns, and multi-system symptom pictures.
Epstein-Barr Virus and its reactivation patterns
EBV causes infectious mononucleosis on initial infection in adolescents and young adults. After acute infection, the virus establishes latency primarily in B lymphocytes and persists for life. Chronic active or persistent EBV represents a continuum of clinical patterns. Specific antibody patterns suggest active versus past infection — the relationship between early antigen (EA) IgG, viral capsid antigen (VCA) IgG and IgM, and EBNA antibodies. EBV is increasingly implicated in autoimmune disease, chronic fatigue patterns, and post-viral syndromes that overlap with ME/CFS and Long COVID.
Cytomegalovirus and its reactivation patterns
CMV follows a similar pattern — initial infection often subclinical, lifelong latency, capable of reactivation. Subclinical CMV reactivation may contribute to chronic symptoms in some patients. CMV is increasingly studied in connection with chronic inflammation, accelerated immune aging, and the immune dysregulation that contributes to chronic illness.
How iHeal evaluates chronic viral reactivation
The evaluation looks at antibody patterns rather than single antibody titers. For EBV, this means examining the relationship between VCA IgM, VCA IgG, EA IgG, and EBNA IgG to characterize the pattern of activity, with T-cell testing and EBV PCR adding information where relevant. The broader evaluation considers what's driving viral reactivation rather than only documenting that it's occurring — reactivation reflects immune dysregulation, and that dysregulation has contributors: environmental exposures, other chronic infections, hormonal factors, sleep and stress, nutritional status.
Treatment considerations
Antiviral medications have a role in selected patients with documented active reactivation and clinically significant symptoms. Many patients improve substantially with addressing the broader immune dysregulation — supporting mast cell function, mitochondrial capacity, sleep, and nutritional status — without requiring antiviral medication. The clinical judgment is individualized.
Pro Tip · From Dr. Everett
The evaluation looks at antibody patterns rather than single antibody titers. For EBV, this means examining the relationship between VCA IgM, VCA IgG, EA IgG, and EBNA IgG to characterize the pattern of activity, with T-cell testing and EBV PCR adding information where relevant. The broader evaluation considers what's driving viral reactivation rather than only documenting that it's occurring — reactivation reflects immune dysregulation, and that dysregulation has contributors: environmental exposures, other chronic infections, hormonal factors, sleep and stress, nutritional status.
Sources & Further Reading
- CDC: Epstein-Barr Virus cdc.gov/epstein-barr
- CDC: Cytomegalovirus cdc.gov/cmv
- Peer-Reviewed: EBV and autoimmune disease — PubMed-indexed; references in Science, Multiple Sclerosis Journal, Autoimmunity Reviews
- Peer-Reviewed: Chronic active EBV — PubMed-indexed; references in Blood, Clinical Infectious Diseases
Concerned this applies to you?
A consultation is where we figure out whether chronic viral reactivation is actually contributing to your symptoms — and what to do about it.